{"entity":{"id":"stephen-forman","kind":"person","name":"Stephen J. Forman","aka":[],"tldr":"Transplant pioneer who built City of Hope's cell therapy programme, one of the largest in the country.","summary":"Stephen Forman is Director of the Hematologic Malignancies Research Institute and Francis and Kathleen McNamara Distinguished Chair at City of Hope. A haematologist specialising in haematopoietic cell transplantation, CAR-T and lymphoma, he led City of Hope's bone marrow transplant programme for decades and built its cell therapy programme, one of the largest in the country. His papers include a Blood report of phase 1 studies of central memory-derived CD19 CAR T-cell therapy after autologous transplant in B-cell non-Hodgkin lymphoma and a Blood commentary on the myth of the second remission of acute leukaemia in adults. He directs haematologic malignancies research including CAR-T development for lymphoma and leukaemia and off-the-shelf cell therapy.","asOf":"2026-09-08","links":[{"label":"City of Hope research faculty","url":"https://www.cityofhope.org/research/find-a-researcher"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Forman%20SJ%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Stephen%20J.%20Forman"}],"tags":[],"related":[],"cancers":["aml","dlbcl","all-leukemia"],"sections":[],"technologies":["car-t","allogeneic-cell-therapy"],"targets":[],"drugs":[],"companies":[],"institutions":["city-of-hope"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Director, Hematologic Malignancies Research Institute; Francis and Kathleen McNamara Distinguished Chair, City of Hope","institutionId":"city-of-hope","specialisms":["Hematopoietic cell transplantation","CAR-T","Lymphoma"],"profiles":[{"label":"City of Hope research faculty","url":"https://www.cityofhope.org/research/find-a-researcher"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Forman%20SJ%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Stephen%20J.%20Forman"}],"papers":[{"title":"Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL","journal":"Blood","year":2016,"url":"https://doi.org/10.1182/blood-2015-12-686725","doi":"10.1182/blood-2015-12-686725"},{"title":"The myth of the second remission of acute leukemia in the adult","journal":"Blood","year":2013,"url":"https://doi.org/10.1182/blood-2012-08-234492","doi":"10.1182/blood-2012-08-234492"}]},"route":"/people/stephen-forman/","neighbours":{"cancer":[{"id":"all-leukemia","kind":"cancer","name":"Acute lymphoblastic leukaemia","route":"/cancers/all-leukemia/"},{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"}],"technology":[{"id":"allogeneic-cell-therapy","kind":"technology","name":"Allogeneic (off-the-shelf) cell therapy","route":"/technologies/allogeneic-cell-therapy/"},{"id":"car-t","kind":"technology","name":"CAR-T cell therapy","route":"/technologies/car-t/"}],"institution":[{"id":"city-of-hope","kind":"institution","name":"City of Hope","route":"/institutions/city-of-hope/"}]}}